Association Between Shortened Leukocyte Telomere Length and Cardiometabolic Outcomes: Systematic Review and Meta-Analysis

BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is...

Full description

Saved in:
Bibliographic Details
Published inCirculation. Cardiovascular genetics Vol. 8; no. 1; pp. 82 - 90
Main Authors D’Mello, Matthew J.J., Ross, Stephanie A., Briel, Matthias, Anand, Sonia S., Gerstein, Hertzel, Paré, Guillaume
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.02.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting. METHODS AND RESULTS—MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case–control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06–1.37; I=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04–1.47; I=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10–1.72; I=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes. CONCLUSIONS—Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.
AbstractList BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting. METHODS AND RESULTS—MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case–control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06–1.37; I=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04–1.47; I=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10–1.72; I=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes. CONCLUSIONS—Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.
Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting. MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case-control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06-1.37; I(2)=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04-1.47; I(2)=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes. Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.
Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting.BACKGROUNDTelomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and oxidative stress within the cellular environment and ultimately leads to cellular senescence. Shortened leukocyte telomere length is hypothesized to be a novel biomarker for age and age-related diseases, yet reports on its association with cardiometabolic outcomes in the literature are conflicting.MEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case-control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06-1.37; I(2)=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04-1.47; I(2)=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes.METHODS AND RESULTSMEDLINE (1966 to present) and EMBASE (1980 to present) were last searched on September 9, 2013. Reference lists of retrieved citations were hand searched for relevant studies. No restrictions were placed on sample size, language, or publication type or date. Fifteen cohort and 12 case-control studies reporting the association between leukocyte telomere length and stroke, myocardial infarction, and type 2 diabetes mellitus were independently selected for inclusion by 2 reviewers. Data extraction and risk of bias assessment were completed independently by 2 reviewers using predefined criteria. Studies were pooled using the generic inverse variance method and both fixed and random effects models. A 1-SD decrease in leukocyte telomere length was significantly associated with stroke (odds ratio, 1.21; 95% confidence interval, 1.06-1.37; I(2)=61%), myocardial infarction (odds ratio, 1.24; 95% confidence interval, 1.04-1.47; I(2)=68%), and type 2 diabetes mellitus (odds ratio, 1.37; 95% confidence interval, 1.10-1.72; I(2)=91%). Stratification by measurement technique, study design, study size, and ethnicity explained heterogeneity in certain cardiometabolic outcomes.Shortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.CONCLUSIONSShortened leukocyte telomere length demonstrates a significant association with stroke, myocardial infarction, and type 2 diabetes mellitus. Larger, well-designed studies are needed to confirm these findings and explore sources of heterogeneity.
Author Anand, Sonia S.
Gerstein, Hertzel
D’Mello, Matthew J.J.
Briel, Matthias
Paré, Guillaume
Ross, Stephanie A.
AuthorAffiliation From the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada (M.J.J.D., S.A.R., S.S.A., H.G., G.P.); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, Switzerland (M.B.); and Department of Clinical Epidemiology and Biostatistics (M.B., S.S.A., H.G., G.P.), Department of Medicine (S.S.A., H.G.), and Department of Pathology and Molecular Medicine (G.P.), McMaster University, Hamilton, Ontario, Canada
AuthorAffiliation_xml – name: From the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada (M.J.J.D., S.A.R., S.S.A., H.G., G.P.); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, Switzerland (M.B.); and Department of Clinical Epidemiology and Biostatistics (M.B., S.S.A., H.G., G.P.), Department of Medicine (S.S.A., H.G.), and Department of Pathology and Molecular Medicine (G.P.), McMaster University, Hamilton, Ontario, Canada
Author_xml – sequence: 1
  givenname: Matthew
  surname: D’Mello
  middlename: J.J.
  fullname: D’Mello, Matthew J.J.
  organization: From the Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada (M.J.J.D., S.A.R., S.S.A., H.G., G.P.); Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, Switzerland (M.B.); and Department of Clinical Epidemiology and Biostatistics (M.B., S.S.A., H.G., G.P.), Department of Medicine (S.S.A., H.G.), and Department of Pathology and Molecular Medicine (G.P.), McMaster University, Hamilton, Ontario, Canada
– sequence: 2
  givenname: Stephanie
  surname: Ross
  middlename: A.
  fullname: Ross, Stephanie A.
– sequence: 3
  givenname: Matthias
  surname: Briel
  fullname: Briel, Matthias
– sequence: 4
  givenname: Sonia
  surname: Anand
  middlename: S.
  fullname: Anand, Sonia S.
– sequence: 5
  givenname: Hertzel
  surname: Gerstein
  fullname: Gerstein, Hertzel
– sequence: 6
  givenname: Guillaume
  surname: Paré
  fullname: Paré, Guillaume
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25406241$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1DAUhS1URB_0L0CWbFL8ysNILIZoWkYaqNQZpO4sx7lhTJ242E5H-feYTosQGxaW7aPv3Gufe4qORjcCQm8JviCkJO-b1U1ztfy63K6aTVLYBcaY18ULdEIEpzmjZX3051zcHqPTEH5gXHLGylfomBYcl5STEzQvQnDaqGjcmH2CuAcYs83O-QgjdNkapjun5wjZFqwbwEOSxu9xl6mxyxrlO5PUqFpnjc6up6jTNXzINnOIMKSqOruBBwP7R_5LIvPFqOwcTHiNXvbKBjh_2s_Qt8vltvmcr6-vVs1inWtW1CwXBETZqaLV6cEdAeiruuJ9XXW616JXhRYtFR1wSoUqaSt03aeP1nUlegZMszP07lD33rufE4QoBxM0WKtGcFOQpCyqlBcWIqFvntCpHaCT994Mys_yOa4EfDwA2rsQPPRSm_iYXfTKWEmw_D0e-fd4ksLkYTzJX_3jf27xfyc_OPfORvDhzk578HIHysadxISxiosqp5gUmCZPnlYSfwHHvab6
CitedBy_id crossref_primary_10_1016_j_ekir_2017_12_005
crossref_primary_10_1038_mp_2017_48
crossref_primary_10_1177_1535370220931509
crossref_primary_10_1111_add_15312
crossref_primary_10_3389_fcell_2021_618335
crossref_primary_10_1016_j_hlc_2019_12_012
crossref_primary_10_1038_npp_2017_125
crossref_primary_10_1098_rstb_2016_0436
crossref_primary_10_1016_j_biopsycho_2019_03_013
crossref_primary_10_1016_j_psyneuen_2015_10_018
crossref_primary_10_1016_j_mad_2024_111929
crossref_primary_10_1186_s12967_020_02551_1
crossref_primary_10_1373_jalm_2016_022137
crossref_primary_10_1016_j_jacc_2016_03_541
crossref_primary_10_1007_s11262_023_02010_1
crossref_primary_10_1146_annurev_clinpsy_032816_045054
crossref_primary_10_1371_journal_pone_0293589
crossref_primary_10_3945_jn_116_234922
crossref_primary_10_3390_cancers17020257
crossref_primary_10_1111_cen_13918
crossref_primary_10_1098_rstb_2017_0151
crossref_primary_10_1161_ATVBAHA_115_305838
crossref_primary_10_1016_j_bbi_2016_02_002
crossref_primary_10_1016_j_jacc_2016_03_530
crossref_primary_10_1016_j_amjcard_2015_03_060
crossref_primary_10_1016_j_atherosclerosis_2019_03_010
crossref_primary_10_1016_j_biopsycho_2019_107809
crossref_primary_10_3390_jcm8040511
crossref_primary_10_3389_fcvm_2021_812363
crossref_primary_10_3390_ijms23158672
crossref_primary_10_1093_aje_kwv203
crossref_primary_10_3390_nu10121942
crossref_primary_10_1038_s41580_020_00314_w
crossref_primary_10_17116_terarkh2017896102_109
crossref_primary_10_1016_j_numecd_2024_103830
crossref_primary_10_1002_JPER_20_0269
crossref_primary_10_1007_s12011_019_1656_3
crossref_primary_10_1016_j_bcmd_2021_102563
crossref_primary_10_1017_S2040174420000355
crossref_primary_10_1016_j_pcad_2017_04_001
crossref_primary_10_17352_jbm_000025
crossref_primary_10_1016_j_sleh_2019_12_003
crossref_primary_10_1038_s41598_020_66729_9
crossref_primary_10_18632_oncotarget_22509
crossref_primary_10_1016_j_cpnec_2021_100029
crossref_primary_10_1097_GME_0000000000000890
crossref_primary_10_3390_microorganisms11071818
crossref_primary_10_3390_ijms20215508
crossref_primary_10_15829_1728_8800_2022_3272
crossref_primary_10_1016_j_jpeds_2019_08_040
crossref_primary_10_1016_j_jab_2016_09_004
crossref_primary_10_14814_phy2_15910
crossref_primary_10_1016_j_psyneuen_2017_10_003
crossref_primary_10_1080_14659891_2023_2239345
crossref_primary_10_1038_s41598_020_79615_1
crossref_primary_10_1111_jdi_13470
crossref_primary_10_1038_s41598_018_36756_8
crossref_primary_10_1161_CIRCRESAHA_118_312567
crossref_primary_10_1111_hel_12760
crossref_primary_10_1161_CIRCRESAHA_117_311751
crossref_primary_10_1161_CIRCRESAHA_118_312202
crossref_primary_10_1186_s12877_019_1383_9
crossref_primary_10_1038_s41598_023_35912_z
crossref_primary_10_1016_j_jacc_2016_01_061
crossref_primary_10_18632_aging_203849
crossref_primary_10_3390_ijerph18041848
crossref_primary_10_30629_2618_6667_2024_22_6_16_26
crossref_primary_10_3390_brainsci12020259
crossref_primary_10_1016_j_biopsycho_2022_108446
crossref_primary_10_1177_08982643251313923
crossref_primary_10_1002_jbmr_4261
crossref_primary_10_18632_aging_203285
crossref_primary_10_1016_j_jaad_2017_11_026
crossref_primary_10_1038_s41598_022_17246_4
crossref_primary_10_1016_j_jamda_2016_04_021
crossref_primary_10_1002_gps_5390
crossref_primary_10_1371_journal_pone_0133174
crossref_primary_10_1016_j_cjca_2021_10_012
crossref_primary_10_3389_fragi_2022_1044038
crossref_primary_10_3390_dna4020011
crossref_primary_10_1016_j_ebiom_2022_103978
crossref_primary_10_1016_j_neulet_2019_04_020
crossref_primary_10_1161_CIRCGENETICS_117_001718
crossref_primary_10_18632_aging_102627
crossref_primary_10_3390_cells10020395
crossref_primary_10_1016_j_arr_2021_101411
crossref_primary_10_2174_1568026620666200131125110
crossref_primary_10_3390_ijerph18179380
crossref_primary_10_4137_GRSB_S39836
crossref_primary_10_1007_s42764_024_00123_x
crossref_primary_10_1016_j_exger_2018_06_027
crossref_primary_10_1155_2020_9256107
crossref_primary_10_12688_f1000research_14068_1
crossref_primary_10_3389_fnagi_2016_00300
crossref_primary_10_1016_j_atherosclerosis_2021_08_013
crossref_primary_10_3389_fendo_2018_00309
crossref_primary_10_1371_journal_pone_0195963
crossref_primary_10_3389_fendo_2021_650922
crossref_primary_10_3389_fgene_2017_00198
crossref_primary_10_1161_JAHA_116_004105
crossref_primary_10_3390_nu14235191
crossref_primary_10_1002_ajhb_23375
crossref_primary_10_1183_16000617_0041_2021
crossref_primary_10_1016_j_neubiorev_2017_11_002
crossref_primary_10_1016_j_trecan_2017_02_005
crossref_primary_10_1093_aje_kwae181
crossref_primary_10_1016_j_banm_2022_02_018
crossref_primary_10_1038_ejcn_2016_93
crossref_primary_10_1111_jth_13689
crossref_primary_10_3390_ijms18122573
crossref_primary_10_1098_rstb_2016_0441
crossref_primary_10_3390_biomedicines11123211
crossref_primary_10_18632_oncotarget_18167
crossref_primary_10_1016_j_copsyc_2018_11_009
crossref_primary_10_1113_JP273689
crossref_primary_10_34067_KID_0000000603
crossref_primary_10_1038_s41598_019_43387_0
crossref_primary_10_1093_ejendo_lvad015
crossref_primary_10_1016_j_kint_2020_02_034
crossref_primary_10_3390_nu15204373
crossref_primary_10_1016_j_neubiorev_2019_03_010
crossref_primary_10_3390_cells7110193
crossref_primary_10_1371_journal_pone_0237477
crossref_primary_10_3390_nu13082585
crossref_primary_10_1016_j_psyneuen_2018_10_019
crossref_primary_10_1093_eurjpc_zwaa115
crossref_primary_10_1007_s00125_020_05242_0
crossref_primary_10_1016_j_envres_2022_112810
crossref_primary_10_1016_j_jacc_2017_05_034
crossref_primary_10_1016_j_psyneuen_2016_02_007
crossref_primary_10_1016_j_psyneuen_2019_04_018
crossref_primary_10_1007_s11883_023_01082_6
crossref_primary_10_1093_gerona_glaa190
crossref_primary_10_1016_j_atherosclerosis_2017_09_016
crossref_primary_10_1186_s12933_022_01635_0
crossref_primary_10_1111_ijpo_12136
crossref_primary_10_1096_fj_201901275R
crossref_primary_10_1002_em_21991
crossref_primary_10_3390_biomedicines9101335
crossref_primary_10_1016_j_jacbts_2018_07_004
crossref_primary_10_1161_HYPERTENSIONAHA_117_09354
crossref_primary_10_1038_s41598_021_90435_9
crossref_primary_10_1097_PSY_0000000000001220
crossref_primary_10_1016_j_envint_2021_106765
crossref_primary_10_1007_s11357_023_00914_2
crossref_primary_10_18632_aging_101216
crossref_primary_10_3389_fneur_2019_00624
crossref_primary_10_1016_j_psyneuen_2022_105876
crossref_primary_10_3390_genes7040015
crossref_primary_10_1111_1753_0407_13376
crossref_primary_10_1152_ajpheart_00197_2017
crossref_primary_10_1016_j_tice_2022_101925
crossref_primary_10_3389_fphys_2021_789690
crossref_primary_10_3390_ijerph18041743
crossref_primary_10_1007_s00592_022_02004_9
crossref_primary_10_1126_sciadv_aao1617
crossref_primary_10_1371_journal_pone_0160748
crossref_primary_10_3389_fgene_2017_00164
crossref_primary_10_1097_HCO_0000000000000613
crossref_primary_10_18087_cardio_2021_11_n1233
crossref_primary_10_3390_jcdd10120492
crossref_primary_10_1016_j_cjca_2016_02_002
crossref_primary_10_1186_s12888_019_2404_0
crossref_primary_10_1038_s41598_017_06036_y
crossref_primary_10_1016_j_psyneuen_2022_105762
crossref_primary_10_3390_nu13020318
crossref_primary_10_1007_s00129_020_04623_1
crossref_primary_10_1038_s41598_020_61241_6
crossref_primary_10_1111_ggi_12738
crossref_primary_10_1177_0300060516667132
crossref_primary_10_1016_j_rmed_2019_05_009
crossref_primary_10_1016_j_psyneuen_2019_03_002
crossref_primary_10_1371_journal_pone_0268689
crossref_primary_10_1139_cjpp_2018_0582
crossref_primary_10_1161_CIRCRESAHA_117_310698
crossref_primary_10_3389_fcvm_2018_00018
crossref_primary_10_1097_PSY_0000000000000356
crossref_primary_10_1016_j_psychres_2021_113941
crossref_primary_10_1007_s10522_022_10011_0
crossref_primary_10_3945_ajcn_115_116806
crossref_primary_10_1177_0890117120906958
crossref_primary_10_1016_j_jpsychores_2022_110760
crossref_primary_10_3390_antiox12101847
crossref_primary_10_3390_nu14193885
crossref_primary_10_1096_fj_201700630r
crossref_primary_10_1016_j_encep_2020_12_001
crossref_primary_10_1186_s13643_019_1199_x
crossref_primary_10_1177_0300060519882570
crossref_primary_10_1016_j_socscimed_2016_03_029
crossref_primary_10_3390_genes7090058
crossref_primary_10_1016_j_psyneuen_2019_03_012
crossref_primary_10_1016_j_psyneuen_2016_09_006
crossref_primary_10_1093_fampra_cmad064
crossref_primary_10_3390_ijms20123032
crossref_primary_10_3390_ijms22189867
crossref_primary_10_1186_s12916_022_02620_w
crossref_primary_10_1007_s00592_016_0857_x
crossref_primary_10_1016_j_physbeh_2018_11_011
crossref_primary_10_1253_circj_CJ_19_0446
crossref_primary_10_3390_ijms252413671
crossref_primary_10_1186_s12940_021_00778_z
crossref_primary_10_3390_cells9061360
crossref_primary_10_1371_journal_pgen_1006144
crossref_primary_10_1017_S2040174424000291
crossref_primary_10_1016_j_ihj_2018_09_007
crossref_primary_10_1016_j_neubiorev_2022_104526
crossref_primary_10_1371_journal_pone_0180687
crossref_primary_10_1016_j_jacc_2021_05_011
crossref_primary_10_14336_AD_2019_0721
crossref_primary_10_1016_j_annepidem_2019_12_009
crossref_primary_10_1016_j_arr_2019_02_003
crossref_primary_10_1080_10615806_2016_1261286
crossref_primary_10_1016_j_rccar_2019_11_001
crossref_primary_10_1161_CIRCGENETICS_114_000964
crossref_primary_10_3390_cells8050381
crossref_primary_10_3390_biom12010039
crossref_primary_10_14336_AD_2023_0115
crossref_primary_10_1007_s11033_024_10077_8
crossref_primary_10_1093_gerona_glab193
crossref_primary_10_1080_10408398_2021_1952402
crossref_primary_10_3390_nu16172963
crossref_primary_10_7759_cureus_10794
crossref_primary_10_3917_heg_123_0269
crossref_primary_10_1161_JAHA_120_020606
crossref_primary_10_1186_s13104_017_2791_6
crossref_primary_10_1016_j_socscimed_2024_117229
crossref_primary_10_1097_PSY_0000000000000383
crossref_primary_10_1097_JOM_0000000000001102
crossref_primary_10_1093_jnci_djy189
crossref_primary_10_2196_45535
crossref_primary_10_1016_j_bbii_2023_100023
crossref_primary_10_1038_s41467_025_57794_7
crossref_primary_10_1080_09553002_2021_1956010
crossref_primary_10_1038_tp_2016_164
crossref_primary_10_1093_aje_kwy124
crossref_primary_10_1177_1747493018772800
crossref_primary_10_1080_15384101_2020_1728016
crossref_primary_10_1093_mutage_gey015
crossref_primary_10_1089_chi_2017_0159
crossref_primary_10_7717_peerj_15085
crossref_primary_10_1016_j_mrrev_2020_108309
crossref_primary_10_1136_heartjnl_2019_315629
crossref_primary_10_18632_aging_103459
crossref_primary_10_1136_heartjnl_2020_318654
crossref_primary_10_1161_CIRCRESAHA_116_310517
crossref_primary_10_26416_Med_158_2_2024_9543
crossref_primary_10_1097_MCO_0000000000000477
crossref_primary_10_1002_mef2_50
Cites_doi 10.1371/journal.pone.0034948
10.1016/S0140-6736(03)12384-7
10.1038/sj.onc.1202797
10.1016/j.cca.2009.02.004
10.1161/01.RES.0000233315.38086.bc
10.1007/s00125-002-1009-0
10.1161/ATVBAHA.110.205492
10.1006/excr.1995.1213
10.1210/jc.2011-1562
10.1093/aje/kwj346
10.1016/j.mrfmmm.2011.04.003
10.2337/db12-0241
10.2337/db13-0744
10.1161/HYPERTENSIONAHA.108.123752
10.1093/gerona/glp061
10.1073/pnas.85.18.6622
10.1093/gerona/glq224
10.2337/diab.44.4.369
10.1371/journal.pone.0019687
10.1097/00004647-200102000-00001
10.1146/annurev.physiol.010908.163111
10.1016/S0140-6736(06)68967-8
10.1016/j.atherosclerosis.2009.09.070
10.1007/s11010-012-1276-0
10.1016/j.atherosclerosis.2009.03.034
10.1038/345458a0
10.1038/ncomms2602
10.1111/ene.12135
10.1042/CS20120691
10.1111/j.1474-9726.2005.00171.x
10.1038/ng.2528
10.1016/S0014-5793(99)00748-6
10.1089/rej.2009.0975
10.2174/092986707779313381
10.1161/01.ATV.0000067426.96344.32
10.1093/epirev/mxs008
10.1161/STROKEAHA.111.637207
10.1038/jhh.2011.57
10.1016/j.trsl.2009.09.012
10.1371/journal.pone.0068254
10.1001/jama.1979.03290450033020
10.1111/j.1474-9726.2009.00470.x
10.1093/gerona/glq164
10.1161/ATVBAHA.111.237271
10.1161/ATVBAHA.110.217158
ContentType Journal Article
Copyright 2015 American Heart Association, Inc.
2014 American Heart Association, Inc.
Copyright_xml – notice: 2015 American Heart Association, Inc.
– notice: 2014 American Heart Association, Inc.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/CIRCGENETICS.113.000485
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1942-3268
EndPage 90
ExternalDocumentID 25406241
10_1161_CIRCGENETICS_113_000485
01337497-201502000-00013
Genre Meta-Analysis
Systematic Review
Journal Article
GroupedDBID ---
.XZ
.Z2
29B
53G
5GY
5VS
AAAAV
AAHPQ
AAIQE
AAJCS
AARTV
AASCR
ABASU
ABBUW
ABDIG
ABJNI
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACEWG
ACGFS
ACILI
ACPRK
ACWDW
ACWRI
ACXJB
ACXNZ
ADBBV
ADGGA
ADHPY
ADNKB
AEBDS
AEETU
AFBFQ
AFDTB
AFEXH
AFNMH
AFUWQ
AHQNM
AHQVU
AHRYX
AHVBC
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BQLVK
C45
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
EX3
F5P
FCALG
FL-
GNXGY
GQDEL
H13
HLJTE
HZ~
IKREB
IN~
IPNFZ
KD2
KQ8
KQB
L-C
O9-
ODMTH
ODZKP
OHYEH
OPUJH
OUVQU
OVD
OVDNE
OXXIT
P2P
P6G
RAH
RIG
S4S
TEORI
TR2
TSPGW
V2I
W2D
W3M
W8F
WOW
ZZMQN
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c3583-91e96da5bc624d1eef7874f87dcfc9fa5c9b29de4229a62b9c8f0068879f3e3c3
ISSN 1942-325X
1942-3268
IngestDate Thu Jul 10 21:56:24 EDT 2025
Sun Jul 13 01:33:33 EDT 2025
Tue Jul 01 02:20:31 EDT 2025
Thu Apr 24 23:09:12 EDT 2025
Fri May 16 03:43:26 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords diabetes mellitus, type 2
aging
stroke
myocardial infarction
Language English
License 2014 American Heart Association, Inc.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3583-91e96da5bc624d1eef7874f87dcfc9fa5c9b29de4229a62b9c8f0068879f3e3c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ObjectType-Undefined-4
PMID 25406241
PQID 1657326099
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_1657326099
pubmed_primary_25406241
crossref_citationtrail_10_1161_CIRCGENETICS_113_000485
crossref_primary_10_1161_CIRCGENETICS_113_000485
wolterskluwer_health_01337497-201502000-00013
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-February
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-February
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation. Cardiovascular genetics
PublicationTitleAlternate Circ Cardiovasc Genet
PublicationYear 2015
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_2_26_2
e_1_3_2_27_2
e_1_3_2_28_2
e_1_3_2_29_2
e_1_3_2_41_2
e_1_3_2_40_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_21_2
e_1_3_2_42_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_23_2
e_1_3_2_44_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_25_2
e_1_3_2_46_2
e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_37_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_39_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_32_2
e_1_3_2_10_2
e_1_3_2_31_2
e_1_3_2_5_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_33_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_2_2
e_1_3_2_14_2
e_1_3_2_35_2
25691684 - Circ Cardiovasc Genet. 2015 Feb;8(1):4-7. doi: 10.1161/CIRCGENETICS.114.000964.
References_xml – ident: e_1_3_2_33_2
  doi: 10.1371/journal.pone.0034948
– ident: e_1_3_2_43_2
  doi: 10.1016/S0140-6736(03)12384-7
– ident: e_1_3_2_3_2
  doi: 10.1038/sj.onc.1202797
– ident: e_1_3_2_26_2
  doi: 10.1016/j.cca.2009.02.004
– ident: e_1_3_2_42_2
  doi: 10.1161/01.RES.0000233315.38086.bc
– ident: e_1_3_2_23_2
– ident: e_1_3_2_44_2
  doi: 10.1007/s00125-002-1009-0
– ident: e_1_3_2_15_2
  doi: 10.1161/ATVBAHA.110.205492
– ident: e_1_3_2_7_2
  doi: 10.1006/excr.1995.1213
– ident: e_1_3_2_30_2
  doi: 10.1210/jc.2011-1562
– ident: e_1_3_2_13_2
  doi: 10.1093/aje/kwj346
– ident: e_1_3_2_21_2
  doi: 10.1016/j.mrfmmm.2011.04.003
– ident: e_1_3_2_31_2
  doi: 10.2337/db12-0241
– ident: e_1_3_2_34_2
  doi: 10.2337/db13-0744
– ident: e_1_3_2_18_2
  doi: 10.1161/HYPERTENSIONAHA.108.123752
– ident: e_1_3_2_38_2
  doi: 10.1093/gerona/glp061
– ident: e_1_3_2_2_2
  doi: 10.1073/pnas.85.18.6622
– ident: e_1_3_2_35_2
  doi: 10.1093/gerona/glq224
– ident: e_1_3_2_45_2
  doi: 10.2337/diab.44.4.369
– ident: e_1_3_2_6_2
  doi: 10.1371/journal.pone.0019687
– ident: e_1_3_2_40_2
  doi: 10.1097/00004647-200102000-00001
– ident: e_1_3_2_39_2
  doi: 10.1146/annurev.physiol.010908.163111
– ident: e_1_3_2_10_2
  doi: 10.1016/S0140-6736(06)68967-8
– ident: e_1_3_2_29_2
  doi: 10.1016/j.atherosclerosis.2009.09.070
– ident: e_1_3_2_24_2
  doi: 10.1007/s11010-012-1276-0
– ident: e_1_3_2_28_2
  doi: 10.1016/j.atherosclerosis.2009.03.034
– ident: e_1_3_2_4_2
  doi: 10.1038/345458a0
– ident: e_1_3_2_11_2
  doi: 10.1038/ncomms2602
– ident: e_1_3_2_17_2
  doi: 10.1111/ene.12135
– ident: e_1_3_2_20_2
  doi: 10.1042/CS20120691
– ident: e_1_3_2_37_2
  doi: 10.1111/j.1474-9726.2005.00171.x
– ident: e_1_3_2_47_2
  doi: 10.1038/ng.2528
– ident: e_1_3_2_5_2
  doi: 10.1016/S0014-5793(99)00748-6
– ident: e_1_3_2_19_2
  doi: 10.1089/rej.2009.0975
– ident: e_1_3_2_41_2
  doi: 10.2174/092986707779313381
– ident: e_1_3_2_25_2
  doi: 10.1161/01.ATV.0000067426.96344.32
– ident: e_1_3_2_8_2
  doi: 10.1093/epirev/mxs008
– ident: e_1_3_2_12_2
  doi: 10.1161/STROKEAHA.111.637207
– ident: e_1_3_2_14_2
  doi: 10.1038/jhh.2011.57
– ident: e_1_3_2_32_2
  doi: 10.1016/j.trsl.2009.09.012
– ident: e_1_3_2_16_2
  doi: 10.1371/journal.pone.0068254
– ident: e_1_3_2_9_2
  doi: 10.1001/jama.1979.03290450033020
– ident: e_1_3_2_22_2
  doi: 10.1111/j.1474-9726.2009.00470.x
– ident: e_1_3_2_36_2
  doi: 10.1093/gerona/glq164
– ident: e_1_3_2_27_2
  doi: 10.1161/ATVBAHA.111.237271
– ident: e_1_3_2_46_2
  doi: 10.1161/ATVBAHA.110.217158
– reference: 25691684 - Circ Cardiovasc Genet. 2015 Feb;8(1):4-7. doi: 10.1161/CIRCGENETICS.114.000964.
SSID ssj0064336
Score 2.5377548
SecondaryResourceType review_article
Snippet BACKGROUND—Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by...
Telomeres are repetitive, gene-poor regions that cap the ends of DNA and help maintain chromosomal integrity. Their shortening is caused by inflammation and...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 82
SubjectTerms Aging - metabolism
Aging - pathology
Cellular Senescence
Diabetes Mellitus, Type 2 - metabolism
Diabetes Mellitus, Type 2 - pathology
Humans
Leukocytes - metabolism
Leukocytes - pathology
Myocardial Infarction - metabolism
Myocardial Infarction - pathology
Stroke - metabolism
Stroke - pathology
Telomere - metabolism
Telomere Homeostasis
Title Association Between Shortened Leukocyte Telomere Length and Cardiometabolic Outcomes: Systematic Review and Meta-Analysis
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01337497-201502000-00013
https://www.ncbi.nlm.nih.gov/pubmed/25406241
https://www.proquest.com/docview/1657326099
Volume 8
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ta9swEBZZB2NjjL0ve0OD7VNwF79J1r6V0NJ2TceaBPrNyPKZlabxSBxG90f2d3eyZMVpOtbtizHCkoXu8enOeu6OkPe8z0ExlntRIrmnHQgvKVTkSVXIEIKEyUwHJw-P2f4kOjyNTzudXy3W0rLKttXPa-NK_keq2IZy1VGy_yBZNyg24D3KF68oYbzeSMattXWEq8U3TZ9F5dmbwvK8VJcV9CqYlhcwh54um9LEstVE1AuoEAU60XW5rHCKhiF3Nb2zYQ3rZz1pk5i0jdrB2VzZKmDbmkHSJrji3HWY5Kp8_YeAD5sDH1tsvHe4Opw6sVXca_aZDn9v_WxFr37qup1JN-bOzLIzR6WOMRu1_2T4cUN-dspXRIGH5qTRx3BNm9XYyQYwjfY1ZYw2NwWmN4XBwclA0wHHB4ORrmRT52k15YLW03Aff0n3JkdH6Xj3dHyL3A7Q_9ClMT5_dcdTaMXVtSfd5CxxEF_08Q-vWTd7NnyZe-T-j1LTIxbndXREy8YZPyQPrHNCdwzSHpEOzB6TO0NLv3hCLluAoxZw1AGOOsDRBnDUAI6ifOgVwNEGcJ_oCm7UwK1-fg1uT8lkb3c82Pds7Q5PhXGiCR0gWC7jTLEgyn2AAneGqEh4rgolChkrkQUihygIhGRBJlRS6HClhIsihFCFz8jWrJzBC0JBoQ-MzWhrZVE_gayI0SwGkSch5zITXcKapU2VTWyv66tM09rBZX7algm2hKmRSZf0XcfvJrfL37u8a2SXoh7Wh2tyBuVykfos5ggFdLi65LkRqhs0QLcIl8HvEm9NyqmJdU7RDQt5JLinv4p-k-zBD1_e4G2vyN3Vt_SabFXzJbxBO7nK3taY_Q1if8B6
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+between+shortened+leukocyte+telomere+length+and+cardiometabolic+outcomes%3A+systematic+review+and+meta-analysis&rft.jtitle=Circulation.+Cardiovascular+genetics&rft.au=D%27Mello%2C+Matthew+J+J&rft.au=Ross%2C+Stephanie+A&rft.au=Briel%2C+Matthias&rft.au=Anand%2C+Sonia+S&rft.date=2015-02-01&rft.issn=1942-3268&rft.eissn=1942-3268&rft.volume=8&rft.issue=1&rft.spage=82&rft_id=info:doi/10.1161%2FCIRCGENETICS.113.000485&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1942-325X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1942-325X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1942-325X&client=summon